English (UK)
中文版
Sangel Capital 
Sangel Capital provides venture capital and business finance to support high-tech enterprises in China and US. The firm seeks to invest in innovative startups in sectors including biopharma, diagnostics, medical devices, and biotech.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Sangel Capital was founded in 2010 and is based in Shenzhen, Beijing with additional offices in Suzhou and Chicago.
Haipeng Cheng
Sanofi
Big Pharma
媛 李
clinicalAmy Sung
Sr launch excellence managernancy jiang
strategy&bd managerMiss Chara Wang
FBPSanten Pharmaceutical 
Santen Pharmaceutical Co., Ltd. (参天製薬株式会社), is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
We are looking for investment and licensing opportunites in the ophthalmology field.
Jessie Tong
Regional Venture Capital ManagerSatyarx Pharma Innovations Private Limited 
Satya is an early-stage Oncology biotech focused on discovering small molecule NCEs, with novel targets against well-established Oncogenes, Tumor suppressors and Synthetic Lethal targets. Satya's team has over 50 years' combined discovery expertise, having worked on over 75 targets and delivered 15 clinical candidates
Mr Murthy Chavali
CEO
Responsive Web Design powered by 